Swiggy shares close up 17 per cent, market cap crosses Rs 1-lakh crore mark

Food-tech unicorn Swiggy, which made a market debut on Wednesday at a modest 7.7% premium over its upper band issue price, saw its shares close 16.92% higher, even as the benchmark indices Sensex and Nifty slipped over 1% amid a broader market weakness.

The company’s shares closed at Rs 456 on the NSE, registering a market capitalisation of about Rs 1.03 lakh crore. Shares opened at Rs 420 against its IPO price of Rs 390.

Also ReadBloodbath on D’Street; Nifty off 10% from recent highs, Sensex slides 1000 points – Is there room for further correction?

The market debut exceeded expectations, as earlier analysts had forecast a muted listing based on the grey market performance.

Also Read FPIs withdraw nearly Rs 20,000 cr from equities in last 5 trading sessions Swiggy IPO subscribed 3.59 times led by QIBs Tata Steel shares gain nearly 2% on strong Q2 performance; Should you Buy, Sell, or Hold? Titan shares fall over 3% after Q2 earnings disappoint; Should you Buy, Sell, or Hold?

The company said it has doubled the categories for quick commerce in the last 12 months, expecting solid growth in the next 3-5 years, and plans to expand its geographical footprint and stores network for the Instamart business.

“We are expecting very solid growth for the next 3-5 years. We are expanding our geographical footprint, stores network for Instamart business,” Swiggy CEO Sriharsha Majety said after the listing ceremony.

Analysts at the global brokerage firm Macquarie initiated coverage of Swiggy shares with an ‘underperform’ rating, recommending a price target of Rs 325 per share.

JM Financial initiated its coverage with a ‘buy’ rating with a target price of Rs 470. “Despite having ceded some space to competition, it is one of the fastest-growing consumption plays with multiple levers to move towards sustainable margins,” it said in a note.

“Despite a subdued market mood and sluggish response from overall investors, Swiggy listing surprised the market participants,” said Prashanth Tapse, senior V-P (research) at Mehta Equities, who recommends holding the stock for the long term.

“This shows investors are positive on the space and the fear of missing out factor is holding investors not to miss the sector growth story, similar to Zomato post listing trend,” he added.

 » Read More

Related Articles

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal

Johnson & Johnson said on Monday it would buy neurological drugmaker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the market for brain disease treatments. The deal would help accelerate growth in J&J’s drugs business after the company spun off its consumer health unit in 2023.

PAG acquires stakes in Manjushree Technopak, Pravesha

Asia Pacific-focused private equity firm PAG, on Monday, announced that it has signed agreements to acquire stakes in Manjushree Technopack. The firm has also acquired majority stakes in pharma focused packaging company Pravesha Industries. While PAG did not disclose valuation details, sources indicate that Manjushree Technopack has been valued at $1 billion, while Pravesha Industries

Hiremaths disclose family arrangement details

Jai and Sugandha Hiremath, promoters of Hikal, have unveiled details of a long-standing family arrangement involving the Kalyani family. The disclosure was made in a stock exchange filing under Sebi’s Listing Obligations and Disclosure Requirements (LODR) Regulations, following a recent Sebi clarification on the need to disclose family agreements still in effect. In their communication

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal

Johnson & Johnson said on Monday it would buy neurological drugmaker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the market for brain disease treatments. The deal would help accelerate growth in J&J’s drugs business after the company spun off its consumer health unit in 2023.

PAG acquires stakes in Manjushree Technopak, Pravesha

Asia Pacific-focused private equity firm PAG, on Monday, announced that it has signed agreements to acquire stakes in Manjushree Technopack. The firm has also acquired majority stakes in pharma focused packaging company Pravesha Industries. While PAG did not disclose valuation details, sources indicate that Manjushree Technopack has been valued at $1 billion, while Pravesha Industries

Hiremaths disclose family arrangement details

Jai and Sugandha Hiremath, promoters of Hikal, have unveiled details of a long-standing family arrangement involving the Kalyani family. The disclosure was made in a stock exchange filing under Sebi’s Listing Obligations and Disclosure Requirements (LODR) Regulations, following a recent Sebi clarification on the need to disclose family agreements still in effect. In their communication

How will markets open today? Here are 7 key cues to watch out for

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 might see a higher start on Tuesday following Asian markets opening on a lower note in early trade hours.  Previously, on Monday, the NSE Nifty 50 closed the session 345.55 points or 1.47% lower at 23,085.95, while the BSE Sensex closed 1,048.90

Stocks To Watch: HCLTech, JSW Energy, United Spirits, BEL, Bank of India, Angel One, Delta Corp

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a positive opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: GIFT Nifty was trading 144 points or 0.62% higher at 23,273 indicating a higher start for domestic indices NSE Nifty 50